CoChat

Fat-Specific Protein 27/CIDEC Promotes Development of Alcoholic Steatohepatitis in Mice and Humans

Open access
Xu, Ming-Jiang, Cai, Yan, Wang, Hua, Altamirano, José, Chang, Binxia, Bertola, Adeline, Odena, Gemma, Lu, Jim, Tanaka, Naoki, Matsusue, Kimihiko, Matsubara, Tsutomu, Mukhopadhyay, Partha, Kimura, Shioko, Pacher, Pal, Gonzalez, Frank J., Bataller, Ramon, Gao, Bin · 2015 · Gastroenterology
Cited by 145

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Background & Aims Alcoholic steatohepatitis (ASH) is the progressive form of alcoholic liver disease and may lead to cirrhosis and hepatocellular carcinoma. We studied mouse models and human tissues to identify molecules associated with ASH progression, and focused on mouse fat-specific protein 27 (FSP-27)/human cell death-inducing DFF45-like effector C (CIDEC) protein, which is expressed in white adipose tissues and promotes formation of fat droplets. Methods C57BL/6N mice or mice with hepatocyte-specific disruption of Fsp27 (Fsp27Hep−/− mice) were fed the Lieber-Decarli ethanol liquid diet (5% ethanol) for 10 days to 12 weeks, followed by 1 or multiple binges of ethanol (5 or 6 g/kg) during the chronic feeding. Some mice were given an inhibitor of the peroxisome proliferator-activated receptor-γ (PPARG) (GW9662). Adenoviral vectors were used to express transgenes or small hairpin (sh) RNAs in cultured hepatocytes and in mice. Liver tissue samples were collected from ethanol-fed mice or from 31 patients with alcoholic hepatitis (AH) with biopsy-proved ASH and analyzed by histologic, immunohistochemical, transcriptome, immunoblot, and real-time PCR analyses. Results Chronic-plus-binge ethanol feeding of mice, which mimics the drinking pattern of patients with AH, produced severe ASH and mild fibrosis. Microarray analyses revealed similar alterations in expression of many hepatic genes in ethanol-fed mice and humans with ASH, including upregulation of mouse Fsp27 (also called Cidec) and human CIDEC. Fsp27Hep−/− mice and mice given injections of adenovirus-Fsp27shRNA had markedly reduced ASH following chronic-plus-binge ethanol feeding. Inhibition of PPARG and cyclic AMP-responsive element binding protein H (CREBH) prevented the increases in Fsp27α and FSP27β mRNAs, respectively, and reduced liver injury in this chronic-plus-binge ethanol feeding model. Overexpression of FSP27 and ethanol exposure had synergistic effects in inducing production of mitochondrial reactive oxygen species and damage to hepatocytes in mice. Hepatic CIDEC mRNA expression was increased in patients with AH and correlated with the degree of hepatic steatosis and disease severity including mortality. Conclusion In mice, chronic-plus-binge ethanol feeding induces ASH that mimics some histological and molecular features observed in patients with AH. Hepatic expression of FSP27/CIDEC is highly upregulated in mice following chronic-plus-binge ethanol feeding and in patients with AH; this upregulation contributes to alcohol-induced liver damage.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1053/j.gastro.2015.06.009

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 41

  1. Tsukamoto, 2001, Current concepts in the pathogenesis of alcoholic liver injury, FASEB J, 15, 1335, 10.1096/fj.00-0650rev · DOI · Paper page
  2. Williams, 2014, New advances in molecular mechanisms and emerging therapeutic targets in alcoholic liver diseases, World J Gastroenterol, 20, 12908, 10.3748/wjg.v20.i36.12908 · DOI
  3. Lucey, 2009, Alcoholic hepatitis, N Engl J Med, 360, 2758, 10.1056/NEJMra0805786 · DOI · Paper page
  4. Singal, 2014, Alcoholic hepatitis: current challenges and future directions, Clin Gastroenterol Hepatol, 12, 555, 10.1016/j.cgh.2013.06.013 · DOI · Paper page
  5. Mathurin, 2012, Management of alcoholic hepatitis, J Hepatol, 56, S39, 10.1016/S0168-8278(12)60005-1 · DOI
  6. Chayanupatkul, 2014, Alcoholic hepatitis: a comprehensive review of pathogenesis and treatment, World J Gastroenterol, 20, 6279, 10.3748/wjg.v20.i20.6279 · DOI
  7. Thursz, 2015, Prednisolone or pentoxifylline for alcoholic hepatitis, N Engl J Med, 372, 1619, 10.1056/NEJMoa1412278 · DOI · Paper page
  8. Brandon-Warner, 2012, Rodent models of alcoholic liver disease: of mice and men, Alcohol, 46, 715, 10.1016/j.alcohol.2012.08.004 · DOI · Paper page
  9. Ueno, 2012, Mouse intragastric infusion (iG) model, Nat Protoc, 7, 771, 10.1038/nprot.2012.014 · DOI · Paper page
  10. Lazaro, 2015, Osteopontin deficiency does not prevent but promotes alcoholic neutrophilic hepatitis in mice, Hepatology, 61, 129, 10.1002/hep.27383 · DOI · Paper page
  11. Bertola, 2013, Mouse model of chronic and binge ethanol feeding (the NIAAA model), Nat Protoc, 8, 627, 10.1038/nprot.2013.032 · DOI · Paper page
  12. Xu, 2012, CIDE proteins and lipid metabolism, Arterioscler Thromb Vasc Biol, 32, 1094, 10.1161/ATVBAHA.111.241489 · DOI · Paper page
  13. Matsusue, 2008, Hepatic steatosis in leptin-deficient mice is promoted by the PPARgamma target gene Fsp27, Cell Metab, 7, 302, 10.1016/j.cmet.2008.03.003 · DOI · Paper page
  14. Yonezawa, 2011, Which CIDE are you on? Apoptosis and energy metabolism, Mol Biosyst, 7, 91, 10.1039/C0MB00099J · DOI
  15. Gong, 2009, CIDE proteins and metabolic disorders, Curr Opin Lipidol, 20, 121, 10.1097/MOL.0b013e328328d0bb · DOI · Paper page
  16. Puri, 2007, Fat-specific protein 27, a novel lipid droplet protein that enhances triglyceride storage, J Biol Chem, 282, 34213, 10.1074/jbc.M707404200 · DOI · Paper page
  17. Nishino, 2008, FSP27 contributes to efficient energy storage in murine white adipocytes by promoting the formation of unilocular lipid droplets, J Clin Invest, 118, 2808
  18. Hall, 2010, Hepatic expression of cell death-inducing DFFA-like effector C in obese subjects is reduced by marked weight loss, Obesity (Silver Spring), 18, 417, 10.1038/oby.2009.236 · doi:10.1038/oby.2009.236
  19. Aibara, 2013, Expression of hepatic fat-specific protein 27 depends on the specific etiology of fatty liver, Biol Pharm Bull, 36, 1766, 10.1248/bpb.b13-00351 · DOI
  20. Zatloukal, 2007, From Mallory to Mallory-Denk bodies: what, how and why?, Exp Cell Res, 313, 2033, 10.1016/j.yexcr.2007.04.024 · DOI · Paper page
  21. Xu, 2015, Transcriptional activation of Fsp27 by the liver-enriched transcription factor CREBH promotes lipid droplet growth and hepatic steatosis, Hepatology, 61, 857, 10.1002/hep.27371 · DOI
  22. Langhi, 2015, CIDEC/FSP27 is regulated by peroxisome proliferator-activated receptor alpha and plays a critical role in fasting- and diet-induced hepatosteatosis, Hepatology, 61, 1227, 10.1002/hep.27607 · DOI
  23. Zhang, 2006, Endoplasmic reticulum stress activates cleavage of CREBH to induce a systemic inflammatory response, Cell, 124, 587, 10.1016/j.cell.2005.11.040 · DOI · Paper page
  24. Claros, 1996, Computational method to predict mitochondrially imported proteins and their targeting sequences, Eur J Biochem, 241, 779, 10.1111/j.1432-1033.1996.00779.x · DOI · Paper page
  25. Dominguez, 2008, A new scoring system for prognostic stratification of patients with alcoholic hepatitis, Am J Gastroenterol, 103, 2747, 10.1111/j.1572-0241.2008.02104.x · DOI · Paper page
  26. Bosch, 2009, The clinical use of HVPG measurements in chronic liver disease, Nat Rev Gastroenterol Hepatol, 6, 573, 10.1038/nrgastro.2009.149 · DOI · Paper page
  27. Lee, 2012, Pharmacological ER stress promotes hepatic lipogenesis and lipid droplet formation, Am J Transl Res, 4, 102
  28. Moran-Salvador, 2011, Role for PPARgamma in obesity-induced hepatic steatosis as determined by hepatocyte- and macrophage-specific conditional knockouts, FASEB J, 25, 2538, 10.1096/fj.10-173716 · DOI · Paper page
  29. Matsusue, 2003, Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes, J Clin Invest, 111, 737, 10.1172/JCI200317223 · DOI · Paper page
  30. Ratziu, 2010, Long-term efficacy of rosiglitazone in nonalcoholic steatohepatitis: results of the fatty liver improvement by rosiglitazone therapy (FLIRT 2) extension trial, Hepatology, 51, 445, 10.1002/hep.23270 · DOI · Paper page
  31. Yu, 2012, Inhibition of hepatic stellate cell activation and liver fibrosis by fat-specific protein 27, Mol Cell Biochem, 369, 35, 10.1007/s11010-012-1366-z · DOI
  32. Tanaka, 2015, Adipocyte-specific disruption of fat-specific protein 27 causes hepatosteatosis and insulin resistance in high-fat diet-fed mice, J Biol Chem, 290, 3092, 10.1074/jbc.M114.605980 · DOI · Paper page
  33. Bertola, 2013, Chronic plus binge ethanol feeding synergistically induces neutrophil infiltration and liver injury in mice: a critical role for E-selectin, Hepatology, 58, 1814, 10.1002/hep.26419 · DOI · Paper page
  34. Dominguez, 2008, A new scoring system for prognostic stratification of patients with alcoholic hepatitis, Am J Gastroenterol, 103, 2747, 10.1111/j.1572-0241.2008.02104.x · DOI · Paper page
  35. Bosch, 2009, The clinical use of HVPG measurements in chronic liver disease, Nat Rev Gastroenterol Hepatol, 6, 573, 10.1038/nrgastro.2009.149 · DOI · Paper page
  36. Affo, 2013, Transcriptome analysis identifies TNF superfamily receptors as potential therapeutic targets in alcoholic hepatitis, Gut, 62, 452, 10.1136/gutjnl-2011-301146 · DOI · Paper page
  37. Ki, 2010, Interleukin-22 treatment ameliorates alcoholic liver injury in a murine model of chronic-binge ethanol feeding: role of signal transducer and activator of transcription 3, Hepatology, 52, 1291, 10.1002/hep.23837 · DOI · Paper page
  38. Matsusue, 2008, Hepatic steatosis in leptin-deficient mice is promoted by the PPARgamma target gene Fsp27, Cell Metab, 7, 302, 10.1016/j.cmet.2008.03.003 · DOI · Paper page
  39. Zhang, 2006, Endoplasmic reticulum stress activates cleavage of CREBH to induce a systemic inflammatory response, Cell, 124, 587, 10.1016/j.cell.2005.11.040 · DOI · Paper page
  40. Sun, 2006, STAT1 contributes to dsRNA inhibition of liver regeneration after partial hepatectomy in mice, Hepatology, 44, 955, 10.1002/hep.21344 · DOI · Paper page
  41. Iimuro, 1997, Female rats exhibit greater susceptibility to early alcohol-induced liver injury than males, Am J Physiol, 272, G1186

Cited by

See all 145

Metadata

Authors
Xu, M.-J., Cai, Y., Wang, H., Altamirano, J., Chang, B., Bertola, A., Odena, G., Lu, J., Tanaka, N., Matsusue, K., Matsubara, T., Mukhopadhyay, P., Kimura, S., Pacher, P., Gonzalez, F. J., Bataller, R., & Gao, B.
Venue
Gastroenterology
Publisher
Elsevier BV
Published
2015-10
Volume
149
Issue
4
Pages
1030-1041.e6
ISSN
0016-5085 (ISSN-L)
OpenAlex
W2100993843
Cited by
145
References
5
FWCI
11.24
Type
journal article
Language
en
Open access
bronze
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Funders
  • National Institutes of Health (1U01AA021908-01, 2012CB518002, 81470557)
  • National Key Research and Development Program of China (1U01AA021908-01, 2012CB518002, 81470557)
  • National Institute on Alcohol Abuse and Alcoholism (1U01AA021908-01, 2012CB518002, 81470557)
  • National Natural Science Foundation of China (1U01AA021908-01, 2012CB518002, 81470557)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Fat-Specific Protein 27/CIDEC Promotes Development of Alcoholic Steatohepatitis in Mice and Humans. https://app.cochat.ai/papers/10.1053/j.gastro.2015.06.009
The paper
Xu, M.-J., Cai, Y., Wang, H., Altamirano, J., Chang, B., Bertola, A., Odena, G., Lu, J., Tanaka, N., Matsusue, K., Matsubara, T., Mukhopadhyay, P., Kimura, S., Pacher, P., Gonzalez, F. J., Bataller, R., & Gao, B. (2015). Fat-Specific Protein 27/CIDEC Promotes Development of Alcoholic Steatohepatitis in Mice and Humans. Gastroenterology. https://doi.org/10.1053/j.gastro.2015.06.009

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.